GIUGGIOLI, DILIA
 Distribuzione geografica
Continente #
NA - Nord America 19.719
EU - Europa 12.708
AS - Asia 3.468
SA - Sud America 80
AF - Africa 31
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 36.041
Nazione #
US - Stati Uniti d'America 19.617
IT - Italia 4.987
GB - Regno Unito 3.833
SE - Svezia 1.098
SG - Singapore 1.060
CN - Cina 1.029
DE - Germania 700
UA - Ucraina 526
TR - Turchia 454
HK - Hong Kong 426
FR - Francia 377
FI - Finlandia 373
RU - Federazione Russa 256
BG - Bulgaria 220
ID - Indonesia 197
IN - India 87
CA - Canada 63
NL - Olanda 63
IE - Irlanda 58
BR - Brasile 47
BE - Belgio 43
JP - Giappone 38
LT - Lituania 34
VN - Vietnam 34
KR - Corea 31
IR - Iran 28
MY - Malesia 28
BZ - Belize 26
RO - Romania 21
CZ - Repubblica Ceca 19
CH - Svizzera 18
AU - Australia 16
ES - Italia 16
ZA - Sudafrica 14
EU - Europa 13
PL - Polonia 11
AR - Argentina 10
MX - Messico 10
HU - Ungheria 9
IL - Israele 9
TW - Taiwan 9
EG - Egitto 8
CL - Cile 7
PK - Pakistan 7
TH - Thailandia 7
LU - Lussemburgo 6
PT - Portogallo 6
CO - Colombia 5
IQ - Iraq 5
AT - Austria 4
BD - Bangladesh 4
BY - Bielorussia 4
GR - Grecia 4
NZ - Nuova Zelanda 4
PE - Perù 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
EC - Ecuador 3
MA - Marocco 3
NO - Norvegia 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
MD - Moldavia 2
MK - Macedonia 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
Totale 36.041
Città #
Southend 3.361
Santa Clara 2.960
Fairfield 2.598
Woodbridge 1.480
Chandler 1.325
Ashburn 1.270
Houston 1.170
Jacksonville 940
Seattle 917
Wilmington 844
Cambridge 828
Singapore 807
Ann Arbor 740
Nyköping 679
Dearborn 621
Hong Kong 423
Milan 351
Modena 315
Izmir 294
Rome 294
San Diego 284
Beijing 251
Princeton 234
Helsinki 233
Sofia 217
Jakarta 193
New York 171
Eugene 157
Bologna 151
Bremen 120
Redwood City 104
Moscow 102
London 99
Florence 95
Des Moines 90
Shanghai 84
Los Angeles 83
Palermo 79
Naples 70
Atlanta 65
Frankfurt am Main 64
Falls Church 59
Parma 57
Catania 52
Bari 51
Norwalk 50
San Jose 48
Turin 44
Boardman 43
Dublin 43
Guangzhou 40
Padova 40
Brussels 37
Genoa 36
Verona 36
Cagliari 31
Reggio Emilia 31
Munich 28
Belize City 26
Dong Ket 26
Brescia 25
New Delhi 25
Hounslow 24
Kunming 24
Nanjing 24
Toronto 23
Ottawa 21
Chicago 20
Hefei 20
Salerno 20
Treviso 20
Amsterdam 18
Phoenix 18
San Mateo 18
Indiana 17
Kilburn 17
Tokyo 17
Brno 16
Chiswick 16
Bergamo 15
Dallas 15
Napoli 15
Philadelphia 15
Pisa 15
Grafing 14
Jinan 14
Leawood 14
Legnano 14
Messina 14
Venice 14
Johannesburg 12
Mountain View 12
Novara 12
Perugia 12
Saint Louis 12
Trento 12
Cinisello Balsamo 11
Livorno 11
Pescara 11
Reggio Calabria 11
Totale 26.599
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.198
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 711
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 690
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 666
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 300
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 297
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 266
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 256
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 253
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 248
Current treatment of hepatitis C-associated rheumatic diseases. 242
Elevated Troponin Serum Levels in Adult Onset Still's Disease 242
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 236
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 236
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 234
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 228
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 228
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 224
Aortic pulse wave velocity measurement in systemic sclerosis patients. 217
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 214
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 213
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 212
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 208
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 208
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 208
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 205
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 205
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 203
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 203
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 203
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 201
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 200
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 200
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 199
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 197
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 197
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 196
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 196
HCV-related rheumatic manifestations and therapeutic strategies 196
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 195
Associations between Systemic Sclerosis and Thyroid Diseases 195
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 191
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 190
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 188
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 187
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 187
Renal Manifestations of Hepatitis C Virus 182
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 181
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 180
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 179
Scleroderma digital ulcers complicated by infection with fecal pathogens. 179
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 176
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 176
Heart involvement and systemic sclerosis 175
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 175
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 175
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 175
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 175
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 174
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 174
Treatment of HCV-related mixed cryoglobulinemia 174
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 173
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 173
Thymus alterations and systemic sclerosis 172
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 171
The safety of iloprost in systemic sclerosis in a real-life experience 170
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 169
Novel Therapies for Thyroid Autoimmune Diseases 168
Amlodipine in the treatment of Raynaud's phenomenon 167
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 167
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 166
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 166
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 165
Systemic sclerosis following human cytomegalovirus infection 165
Severe alopecia complicating systemic sclerosis 165
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 165
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 164
Procedural pain management in the treatment of scleroderma digital ulcers 163
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 163
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 163
L-Arginine in pregnant scleroderma patients 163
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 162
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 162
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 161
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 160
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 159
Osteomyelitis complicating scleroderma digital ulcers. 158
Platelet gel in the treatment of severe scleroderma skin ulcers. 155
Cardiovascular risk and prostanoids in systemic sclerosis 153
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis 152
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases 152
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 151
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 149
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 148
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 148
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 148
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients 147
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 147
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 146
HCV associated cryoglobulinemic vasculitis 145
Totale 23.260
Categoria #
all - tutte 161.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.940 0 0 0 0 0 1.005 826 775 570 214 333 217
2020/20215.943 384 213 333 460 579 492 1.048 796 315 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/20255.634 472 216 243 827 2.233 1.643 0 0 0 0 0 0
Totale 36.555